SLC26A7: A Potential Drug Target and Biomarker (G115111)

Target Name: SLC26A7

NCBI ID: G115111

SLC26A7

SLC26A7: A Potential Drug Target and Biomarker

SLC26A7 (S26A7_HUMAN) is a protein that is expressed in various tissues of the human body. It is a member of the SLC family, which is known for its involvement in the transport of various molecules across cell membranes. One of the unique aspects of SLC26A7 is its expression pattern, which is highly dependent on the tissue it is expressed in. For example, it is primarily expressed in the liver, heart, and pancreas, and is not found in brain or muscle tissue.

SLC26A7 has also been identified as a potential drug target and biomarker. Its unique expression pattern and the involvement of the SLC family in cell signaling make it an attractive target for drug development. Currently, several SLC26A7-based drugs are being developed as potential therapeutic agents for various diseases, including diabetes, heart disease, and neurodegenerative disorders.

One of the primary mechanisms by which SLC26A7 is involved in disease is its role in intracellular signaling. The SLC26A7 protein is involved in the regulation of various intracellular signaling pathways, including the TGF-β pathway. This pathway is involved in the development and maintenance of tissues, and is a key factor in the development of many diseases, including cancer.

In addition to its involvement in intracellular signaling, SLC26A7 is also involved in the regulation of extracellular signaling. It is involved in the regulation of various signaling pathways that are involved in cell adhesion, migration, and survival. SLC26A7 has also been shown to play a role in the regulation of angiogenesis, which is the process by which new blood vessels are formed.

SLC26A7's unique expression pattern and its involvement in intracellular and extracellular signaling pathways make it an attractive target for drug development. Its potential as a drug target and biomarker make it an important area of research for the development of new therapeutic agents for a variety of diseases.

Protein Name: Solute Carrier Family 26 Member 7

Functions: Acts as a sodium-independent DIDS-sensitive anion exchanger mediating bicarbonate, chloride, sulfate and oxalate transport. May play a role in the maintenance of the electrolyte and acid-base homeostasis in the kidney, by acting as a distal excretory segment-specific anion exchanger. Plays a major role in gastric acid secretion

The "SLC26A7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC26A7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets